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Intercalating agents cause varied and multiple biological effects. These include the inhibition of RNA and 
DNA synthesis, frameshift mutations and protein-associated DNA breaks. However, some non- 
intercalating analogs of intercalating compounds behave similarly. The model of DNA intercalation does 
not adequately explain all these biological effects. It is suggested here that intercalators and similar 
compounds may competitively inhibit the closing reaction of some nicking-closing enzymes. Hypothetical 
mechanisms built on this suggestion are presented for the formation of protein associated DNA breaks, 
frarneshift mutation, inhibition of macromolecular synthesis, and recombination. 
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1. INTRODUCTION 
Over 20 years ago Lerman put forward a 
hypothesis to explain the interaction between 
aminoacridine and DNA [l]. Aminoacridine was 
assumed to intercalate between adjacent DNA 
basepairs. Many different compounds were subse- 
quently shown to form intercalative complexes (see 
fig. 1, I-VII; for review see [2-a]). The main con- 
tribution to the binding energy of the complex 
usually comes from the interaction between the Pi 
electronic system of the intercalated molecule, 
which is invariably aromatic, and the neighbouring 
DNA bases. Ionic interactions with DNA 
phosphates may provide additional stabilization if 
the molecule of intercalator is positively charged, 
while oligopeptide or oligosacharide sidechains 
may form hydrogen bonds with DNA constituents. 
The conformation of DNA changes substantially 
as a result of intercalation. The distance between 
the DNA basepairs adjacent to the intercalator in- 
creases by 1.8-4.5 A while the helix becomes tilted 
* Present address: Institut Jacques Monod, Universite 
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and unwound by 11-26” per intercalating 
molecule. The complex usually has a higher 
melting temperature than uncomplexed DNA, 
reflecting an increase in the stability of the double 
helix. 
The addition of intercalating drugs to cells in 
culture causes many cellular effects including cell 
death, inhibition of cell growth, and transforma- 
tion. Explanations of these effects are commonly 
based on the assumption that the intercalator- 
induced changes in the DNA structure disturb cor- 
rect functioning of some DNA-dependent en- 
zymatic systems. For example, the antibiotic ac- 
tinomycin D is thought to inhibit ribosomal RNA 
synthesis by forming complexes with the DNA 
which obstruct the movement of RNA polymerase 
(review (5, 61). 
However, even in this most studied case, it is not 
clear why actinomycin selectively inhibits rRNA 
synthesis or why some cell lines are resistant o ac- 
tinomycin treatment. There are other biological 
phenomena which are even more difficult to ex- 
plain only on the basis of intercalator-induced 
changes in DNA conformation. These include the 
formation of protein-associated DNA breaks 
(PADB) in bacterial plasmids [7] and in mam- 
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Fig. 1. Intercalating (I-VII) and nonintercalating (VIII-XI) compounds causing biological effects typical for inter- 
calators: (I) chloroquine; (II) proflavine; (III) ethidium; (IV) 4’-(acridinylamino) methanesulfon-m-anisidine, (m- 
AMSA); (V) daunamycin; (VI) 2-methyl-9-hydroxyellipticinium; (VII) actinomycin D; (VIII) n-nitrofluoroacethyl- 
adriamycin-1Cvalerate (AD 32); (IX) nalidixic acid, (X) irehdiamine A; (XI), 3,8-diamino-5-carboxymethyl-6-phenyl- 
phenanthridinium. 
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malian cell nuclei [8-111, and various genetic ef- 
fects such as frameshift mutation [12,13] and 
recombination [ 14,151. 
I propose that these phenomena might be more 
readily explained by supposing that the ‘inter- 
calator’ binds not only to DNA but also to a pro- 
tein of the relevant DNA-dependent enzymatic 
system. Many DNA-dependent cellular processes 
involve enzymes which are able to introduce a 
single strand break or nick into the DNA. These 
enzymes bridge the break, binding covalently to 
one end of the nicked DNA and noncovalently to 
the other end. The reaction is reversible, thus all 
these proteins could be called ‘nicking-closing’ 
enzymes. 
More specifically, I propose that some 
molecules, including, but not limited to inter- 
calators, competitively inhibit this ‘closing’ reac- 
tion by blocking the site on the enzyme normally 
occupied by the non-covalently bound end of the 
nicked DNA. 
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2. COMPETITIVE INHIBITION OF THE 
‘CLOSING’ REACTION 
There are many examples of nicking-closing en- 
zymes. These include the bacterial plasmid DNA- 
relaxing proteins, topoisomerases I and II, lambda 
phage integration (int) protein, E. coli synaptase, 
adenovirus 5 terminal protein, and +X174 cisA 
protein (reviews [16-191). The proteins responsible 
for PADBs in mouse L 1210 nuclei [lO,l l] and for 
illegitimate recombination in X. leavis oocytes [20] 
may also be ‘nicking-closing’ enzymes. Fig. 2 il- 
lustrates the possible mechanism of inhibition of 
the closing reaction which may apply to nicking- 
closing enzymes in general. Features of the model 
include the following: 
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DNA (fig. 2A-D). 
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Fig. 2. Reactions of ‘nicking-closing’ enzyme with DNA and intercalator: (A) unreacted components; (B) weak 
DNA-enzyme complex; (C) the enzyme forms a ‘linker’ with one covalent and one non-covalent protein-DNA bond. 
This structure is in equilibrium with structure (D), in which the protein is bound to DNA by the covalent bond only; 
(E) addition of an inhibitor blocks the noncovalent DNA-binding site on the protein; (F) denaturation of the enzyme 
irreversibly binds it to the DNA. 
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(ii) Formation of a non-covalent bond with the 
other end of the nicked DNA; (Pulleyblank 
and Ellison [21] postulated ahydrogen bond.) 
The model presented here suggests that other 
interactians between the DNA bases and the 
enzyme may also be involved <fig_ 20 
(iii) The ph~s~hodiester bond shuttles between the 
enzyme {fig. 2C,D) and the ribose of the DNA 
backbone (fig. 2B). There is an equilibrium 
between these states (postulated also by 
Clevell and Helsinki [22]). 
(iv) Denaturation by detergents, alkali or acid of 
the enzyme leads to permanent PADB in a 
fraction of the molecules by destroying its 
catalytic site and ‘freezing’ the phosphate 
bond (fig. 2F). 
(v) The non-covalently bound end of the DNA 
oscillates between its complementary strand 
(fig. 2D$ and the binding site on the enzyme 
(fig. 2C). This equilibrium may depend on the 
DNA base sequence. 
(vi) Various compounds may disrupt the non- 
covalent enzyme-DNA binding (fig. 2Q 
Some of these compounds may set as com- 
petitive inhibitors displacing the DNA from its 
binding site and thereby making it impossible 
for the nick to be resealed. The result is a shift 
of the equilibrium towards the complex 2E. 
Intercalating compounds (fig 1, I-VII) might 
be expected to be effective inhibitors of the closing 
reaction of some of these enzymes. Since they are 
able to replace the DNA bases in the base-base 
stacking interactions, it is likely that they can also 
substitute for the DNA bases in the protein-DNA 
interaction, Because these inhibitors of the ‘clos- 
ing’ reaction may bind primarily to the protein site 
rather than to the DNA, one might predict hat: 
1. The extent of inhibition of the closing reaction 
caused by intercalating agents would not cor- 
relate with their DNA binding parameters; 
2. In the extreme case the inhibition of the closing 
reaction could be caused by intercalator-like 
molecules which are unable to intercalate 
because of some structural features uch as a net 
negative charge, a bulky substituent or a 
nonplanar conformation [examples of such 
molecules are shown in fig. 1 (VIII-XI)]; 
3. Another piece of single stranded DNA can 
replace the noncovalently bound end of the 
nicked DNA molecule and, may act as an in- 
hibitor of the closing reaction or may even be 
joined to that DNA. 
There are several reports in the literature which 
are consistent with the above predictions. 
With 1: 
- The strong interealator EtBr produces a much 
lower frequency of PADB in L 1210 cells than 
the weak intercalator m-AMSA [9,11]; 
- The strong intercalator ellipticinium does not 
produce PADB in isolated L 1210 cell nuclei, 
while e~pti~ne and other weaker int~~~tors 
produce a high frequency of PADB in this 
system [IO, il]. 
witk 2: 
- A derivative of the strong intercalator 
adriamycine, AD 32, (fig. 1, VIII) fails to bind 
to DNA; however, it produces ahigh frequency 
of protein associated DNA breaks in L 1210 
cells 1231; 
- Nalidixio (fig. 1,IX) and oxofinic acids 
intercalator-like molecules do not bind to 
DNA, inhibit the resealing reaction of some 
type II topoisomerases (reviews [16- 191). 
- Intercalator-stimulated nucleolytic activity 
from yeast ~t~ho~d~a is s~m~at~ also by 
a ~~boxyl-substituted anafogue of EtBr (fig_ 1% 
XI) which does not intercaiate into DNA [24]. 
One may suspect that this intercalator- 
stimulated fragmentation of DNA is caused, at 
least partially by a nicking-closing enzyme. 
With 3: 
- Topoisornerase activity of lambda int protein is 
inhibited by a single-stranded DNA [25]; 
- Poi~d~d~~ inhibits the action of calf thymus 
topoisomerase on supercoiled DNA resulting 
apparently in the formation of nicked DNA 
molecules [26]; 
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- Synaptase (review [27]), lambda int protein 
[25], and proteins from X. laevis oocytes [20] 
exchange ends from two different DNA 
molecules, a process which results in branched, 
Holliday-type, DNA structures. 
3. BIOLOGICAL EFFECTS OF THE 
INHIBITION OF THE CLOSING 
REACTION 
3.1. Inhibition of macromolecular synthesis 
I will discuss three possible biological conse- 
quences of the inhibition of the resealing reaction 
of the nicking-closing enzymes. The first is linked 
to the fact that the nicking-closing enzyme, unable 
to finish the closing reaction, becomes immobiliz- 
ed and crosslinked to the DNA. Enzymatic 
systems, such as DNA or RNA polymerases, the 
function of which depends upon (unobstructed) 
movement along the DNA are likely to be in- 
hibited. This effect was postulated [28] to explain 
the inhibition of the replication of T4 phage by 
nalidixic acid, a gyrase inhibitor, even though 
replication of this phage does not require a func- 
tional gyrase. By inhibiting the resealing reaction 
of gyrase, nalidixic acid causes gyrase molecules to 
become linked to DNA, thereby impeding poly- 
merase movement. 
A similar effect may be responsible for the selec- 
tive inhibition of mitochondrial DNA replication 
by some intercalating agent (e.g., [29]). Rat liver 
mitochondrial topoisomerase is sensitive to EtBr 
while the nuclear enzyme is not [30]. 
3.2. Frameshift mutation 
The second biological consequence of the inhibi- 
tion of the resealing reaction results from the 
possible release of the noncovalently bound end of 
the DNA from its binding site. Addition or 
removal of bases from the free end might lead to 
frameshift mutations. A model of such an effect is 
presented on fig. 3. In the first step, the 
nicking-closing enzyme produces a nick. A 
molecule of intercalator binds to the enzyme. This 
simultaneously stabilizes the nick and displaces the 
noncovalently bound end of the DNA, which may 
then be exposed to exonucleases. A second 
molecule of intercalating agent may stabilize the 
loop-out in the DNA, as postulated [12]. If the 
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Fig. 3. Proposed mechanism for the formation for 
frameshift mutations: (I) ‘nicking-closing’ enzyme 
nicks the DNA, the noncovalent DNA binding site is 
blocked by an intercalating agent, and an exonuclease 
trims the displaced DNA end; (II) the complementary 
DNA strand forms a loop which is stabilized by another 
molecule of intercalator; (III) after the dissociation of 
intercalator, the ‘nicking-closing’ enzyme reseals the 
break and dissociates. 
loop is close to a region of repetitive DNA se- 
quence, partial base pairing may be restored at 
both sides of the loop (step II). Dissociation of the 
intercalator enables the nicking-closing enzyme to 
finish its closing reaction (step III). Replication of 
such DNAs would result in a frameshift mutation. 
In contrast to the classical Streisinger model 
[12], this model predicts that more than one 
molecule of intercalator is involved in each 
frameshift mutation event, a prediction which is in 
good agreement with experimental results (review 
[31]). Another prediction is that mutagenic activity 
does not necessarily correlate with the DNA bin- 
ding parameters of various intercalating agents. In 
fact attempts to find such a correlation have failed 
(review [32]). One may suppose on the basis of the 
model presented here that the reason for the lack 
of the correlation is the requirement of the binding 
of the mutagen to both DNA and the protein. In 
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addition proteins from different sources may have 
different affinities for a given intercalator. This 
may explain why proflavine causes frameshift 
mutations in a T4 phage system but not in 
Salmonella [32]. 
The model presented here suggests that sequence 
specificities may be involved at several steps in the 
formation of a frameshift mutation: 
(1) The DNA sequence specificity may be involved 
in the positioning of the nicking-closing en- 
zyme on the DNA; 
(2) The base sequence close to the nick should be 
repetitive in order to allow slippage of the DNA 
end; 
(3) The intercalator has to have an affinity towards 
the mismatched sequence; 
(4) The affinity of the end of the nicked DNA 
towards the noncovalent binding site on the 
nicking-closing protein should not be much 
higher than the affinity of the intercalator to 
the same binding site, otherwise the inter- 
calator would not interfere in the nicking- 
closing equilibrium. A DNA base sequence 
fulfilling these requirements might be a muta- 
tional ‘hot spot’. 
3.3. Recombination 
The third biological consequence of the inhibi- 
tion of resealing results when the displaced ends of 
the nicked DNA are exchanged between two dif- 
ferent protein-DNA complexes. An example of 
this effect is the increase of the recombination fre- 
quency in a cell-free lambda phage packaging 
system in the presence of oxolinic acid [33]. This 
effect was interpreted as resulting from the subunit 
exchange between two gyrase-DNA complexes 
fixed by the inhibitor (fig. 4A). This hypothesis im- 
plicitly assumes that a subunit of gyrase (each 
subunit consists of one protomer A and one pro- 
tomer B) forms an interstrand bridge, with one 
covalent and one noncovalent bond, at the site of 
the DNA scission. This assumption is rather 
unlikely since it is known that oxolinic acid at low 
concentrations causes mainly single-stranded DNA 
breaks [34], a fact which cannot be explained by 
the model in fig. 4A. More consistent with the 
known properties of the gyrase is the formation of 
an intrastrand bridge by each subunit (fig. 4B). 
Both the gyrase subunits and the noncovalently 
bound DNA ends are able to exchange, resuiting in 
Fig. 4. Mechanisms of oxolinic acid-stimulated recom- 
bination. (A) mechanism proposed [33]. Gyrase subunits 
from interstrand bridges at a DNA double strand scis- 
sion. Gyrase subunits then exchange. (B) Mechanism 
proposed here. Gyrase subunits form intrastrand bridges 
at a DNA double strand scission. Oxolinic acid displaces 
the noncovalently bound DNA ends (top). Gyrase 
subunits exchange (middle). Displaced DNA ends may 
rebind with different gyrase subunits, leading to recom- 
bination (bottom). 
the recombinational event (fig. 4B, bottom). Ox- 
olinic acid would be expected to stimulate this pro- 
cess by displacing the noncovalently bound DNA 
ends from their binding sites on the protein. Com- 
pared to the other model (fig. 4A), this model sug- 
gests a specific role for oxolinic acid. Similar pro- 
cesses may be involved in recombination in yeast 
caused by daunamycine [14] or in sister chromatid 
exchanges caused by intercalating compounds in 
mammalian cells [15]. 
4. CONCLUDING REMARKS 
The model presented here suggests that some 
biological consequences of many intercalator and 
intercalator-like compounds may result not from 
their binding to DNA but from their binding to 
nicking-closing enzymes. The verification of this 
model will depend on the isolation and charact- 
erization of the appropriate enzymes. This model 
may be useful in explaining the biological effects 
of intercalators and similar compounds which are 
not easily explained otherwise. 
11 
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